Quarterly report · Q1
2160.TEDINET S100QRIK
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥17.4bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.9bn | 2022-01-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥398m | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥479m | 2022-01-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥65m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥768m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥347m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥3m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥389m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥351m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥342m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | −¥868m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥72m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥34.1bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥33.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥32.6bn | at 2022-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥14.3bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥14.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥19.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥20.5bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥21.2bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.0bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥20.3bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥10.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.0bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥710m | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥393m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥426m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥1.2bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.1bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥298m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥52m | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥646m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥331m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-0.06 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥8.19 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥7.4 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-0.06 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥8.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥7.36 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 62.2% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥23m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥623m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥600m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥23m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥248m |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥3.6bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥3.6bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥149m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥4.2bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥4.2bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥23m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥398m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥532m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥532m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥255m |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥3.4bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥3.4bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥224m |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥3.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥3.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | ¥479m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新井 達哉 ㊞ | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)今川 義弘 ㊞ | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior1YTDDuration | 3933490000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYTDDuration | 4206135000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 17418966000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YTDDuration | 347425000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYTDDuration | -64934000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 767887000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YTDDuration | 72289000 | JPY |
| Profit loss IFRS (5-year summary) | CurrentYTDDuration | -341745000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YearDuration | -868252000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 351014000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | -2874000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 388825000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YTDDuration | 1101437000 | JPY |
| Comprehensive income IFRS (5-year summary) | CurrentYTDDuration | -57033000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YearDuration | 187696000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 1355849000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 203671000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 1811272000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1QuarterInstant | 20321859000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentQuarterInstant | 21205560000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 20969692000 | JPY |
| Total assets IFRS (5-year summary) | Prior1QuarterInstant | 32590183000 | JPY |
| Total assets IFRS (5-year summary) | CurrentQuarterInstant | 34070943000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 33906981000 | JPY |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 7.40 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | -0.06 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 8.19 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 7.36 | |
| Diluted earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | -0.06 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 8.11 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1QuarterInstant | 0.624 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | CurrentQuarterInstant | 0.622 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.618 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YTDDuration | 425628000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | CurrentYTDDuration | 709959000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 393320000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YTDDuration | -298202000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -1239778000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -4116163000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | -331129000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | -51798000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -646327000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 14787730000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 10596849000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 11049310000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |